Last reviewed · How we verify
ACE Reno
ACE Reno is an angiotensin-converting enzyme (ACE) inhibitor that works by relaxing blood vessels and reducing blood pressure.
ACE Reno is an angiotensin-converting enzyme (ACE) inhibitor that works by relaxing blood vessels and reducing blood pressure. Used for Hypertension, Heart failure.
At a glance
| Generic name | ACE Reno |
|---|---|
| Sponsor | Ace Cells Lab Limited |
| Drug class | ACE inhibitor |
| Target | Angiotensin-converting enzyme (ACE) |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
ACE Reno blocks the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby reducing peripheral resistance and lowering blood pressure. This mechanism is particularly beneficial in patients with hypertension or heart failure.
Approved indications
- Hypertension
- Heart failure
Common side effects
- Cough
- Dizziness
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ACE Reno CI brief — competitive landscape report
- ACE Reno updates RSS · CI watch RSS
- Ace Cells Lab Limited portfolio CI